Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Retatrutide for Sale > High Purity RT5 Lyophilized Powder Research Grade Peptide
High Purity RT5 Lyophilized Powder Research Grade Peptide buy - large image1
High Purity RT5 Lyophilized Powder Research Grade Peptide buy - image1

High Purity RT5 Lyophilized Powder Research Grade Peptide

6735 Inquiries

Unit Price:

$25-30/UNIT FOB

Get Latest Price
CAS No.:

2381089-83-2

Grade:

Research Grade

Content:

99%

Port:

Shenzhen

Brand:

F

Packaging:

vials

Price valid (until):

2026-11-25

Company Type:
Trader
Location:
Hongkong, China
Qualification:
Main Products:

Retatrutide

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Name:ROSE
    WhatsApp:+852 9094 0023

    Email:janeta.heart15@outlook.com

    Items Specifications
    Tirzepatide 5 mg, 10 mg, 15 mg, 20 mg, 30 mg,60mg
    Form Freeze-dried powder
    Package 10 Vials per box
    MOQ 1 kit (10 vials)

    Why choose us?

    We provide door-to-door service; you do not have to worry about the inconvenience of going out to pick up goods and other problems. Guarantee 100% safe transportation. There is also special line transportation. 100% safe delivery. We spot it, order it, send it immediately, and have a time advantage. Don't worry about the quality either. We have the certificate of qualification.


    Shop Tirzepatide 40mg Vial High Purity Lyophilized Peptide Powder Large Stock-Detailed Image 1

    Our Advantage

    1. Rich experience.
    Our products have exported to New Zealand, UK, USA, Australia, Middle East, and so on other country, and we have got very good feedback from our customers, we had Established long friendly relations of cooperation.

    2. Great quality, purity and favourable.
    Good quality is one of our secret success, welcome order the samples, MOQ just 1 box.

    3. Safe and fast delivery.
    We have stock, so we can delivery quickly at the very day when receive the payment

    4. Good after-sales service.


    Shop Tirzepatide 40mg Vial High Purity Lyophilized Peptide Powder Large Stock-Detailed Image 2 Shop Tirzepatide 40mg Vial High Purity Lyophilized Peptide Powder Large Stock-Detailed Image 3











    Choosing us gives you peace of mind. Shop Tirzepatide 40mg Vial High Purity Lyophilized Peptide Powder Large Stock-Detailed Image 4



    FAQ

    1.Q:What is your production cycle and delivery schedule?

        A:For regular products, the delivery cycle is usually 3 to 7 days. We also have buffer stocks of key materials to ensure a stable and continuous supply.

    2. Q: What are your main export markets?

        A:Our products are sold all over the world, including the United States, Canada, Australia, New Zealand, Mexico and many other countries and regions.

    3. Q: How do you handle the after-sales service and quality issues?

        A:In case of any issues related to quality, transportation or documentation, our team will promptly communicate and provide effective solutions to safeguard the interests of our customers.

    4. Q: How is the quality of the product?

        A: Before each batch of our products is put on the market for sale, they will undergo corresponding quality inspections to ensure that the purity is above 99% and there will be corresponding test reports for reference.


    ECHEMI Editorial Reference
    Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.

    Basic Info
    Product Name:

    Retatrutide

    Other Name:

    Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide

    CAS No.:

    2381089-83-2

    Molecular Formula:

    C221H342N46O68

    Molecular Weight:

    4731.33

    EC Number:

    200-001-8

    Color/Form:

    White lyophilized

    Characteristics
    Water Solubility:

    Soluble in water (5mg/ml).

    Storage Conditions:

    -20°C

    Critical Temperature & Pressure:

    -20°C

    Research
    Class:

    Triple agonist — GCGR, GIPR, GLP-1R

    Status:

    Investigational (Phase 3)

    Mechanism:

    Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.

    EC50 (Human GCGR):

    5.79 nM

    EC50 (Mouse GIPR):

    0.191 nM

    EC50 (Mouse GLP1R):

    0.794 nM

    EC50 (Mouse GCGR):

    2.32 nM

    EC50 (Human GLP1R):

    0.775 nM

    EC50 (Human GIPR):

    0.0643 nM

    Source:

    Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI

    Clinical Development:

    NCT04881760; NCT05882045; NCT06354660

    References
    ChEMBL:

    CHEMBL5095485

    DrugBank:

    DB18993

    KEGG DRUG:

    D12430

    PubChem:

    PubChem

    Disclaimer:

    Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Retatrutide

    Location:

    B27 SHING LEE COMM BLDG 8 WING KUT ST CENTRAL HONG KONG

    Year of Establishment:

    2026

  • Inquiry History
    6735 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Retatrutide 2381089-83-2

    3 MT Mar 28, 2026
    United Kingdom

    Retatrutide - 2381089-83-2

    1 G Feb 10, 2026
    United States

    Retatrutide CAS 2381089-83-2 10mg vial

    20 MT Mar 7, 2026
    United States

    Factory Retatrutide API 99% Purity CAS 2381089-83-2

    5 KG Nov 10, 2025
    United Kingdom

    Peptide powder Retatrutide 99% pure for Body building cas 2381089-83-2 Weight Loss Peptide with COA

    1 MT Mar 22, 2026
    United States

    2381089-83-2

    100 G Jul 14, 2026
    United States

    2381089-83-2

    100 G Feb 24, 2026
    United States

    2381089-83-2

    100 MT Dec 9, 2023
    United States

    Retatrutide 2381089-83-2

    200 MG May 16, 2026
    United Kingdom

    2381089-83-2 retatrutide

    300 MG Feb 13, 2026
    United States

    Retatrutide 2381089-83-2 wholesale

    500 MT Nov 3, 2023
    United States

    Retatrutide CAS 2381089-83-2 99%

    10 PCS Feb 21, 2026
    Poland

    CAS 2381089-83-2 (Custom Peptide)

    40 MT Apr 10, 2026
    Austria

    Peptide Retatruide CAS 2381089-83-2

    100 MT Apr 4, 2026
    Austria

    Retatrutide CAS 2381089-83-2 10mg vial

    20 PCS Feb 10, 2026
    United States

    Tirzepatide 99.9% Liquid 2381089-83-2 TeruiOP

    1 MT Sep 6, 2023
    United States

    Retatrutide/LY3437943/GIPR/GLP-1R 98% Powder 2381089-83-2 Senwayer

    1 G Sep 3, 2023
    United States

    GLP-1 / GIP Retatrutide cas 2381089-83-2

    1 MT Oct 16, 2024
    United States

    Retatrutide 99% High Quality CAS 2381089-83-2

    1 G Jan 23, 2026
    United States

    Injection Peptide Tirzepatide/Retatrutide/ Semaglutide Peptides CAS 2381089-83-2

    10  Oct 21, 2023
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.